Drive Medical returns to roots 

PORT WASHINGTON, N.Y. - Drive DeVilbiss Healthcare is returning to its original brand Drive Medical across all markets. 

The company says the move reflects a return to its roots and establishes a brand platform designed to support continued leadership, future acquisitions and global partnerships. 

“The return to Drive Medical allows us to honor our heritage while presenting a cohesive identity that will guide our future growth,” said CEO Derek Lampert. “When our founders chose the name ‘Drive,’ they chose it for its meaning—momentum, purpose and a determination to push health care forward. That meaning has only grown stronger as we’ve evolved. Today, returning to Drive Medical brings our people, products and global partners back under a single, recognizable name that reflects our commitment to innovation, quality and patient-centered solutions.” 

Over the years, Drive has grown through innovation and strategic acquisitions, expanding its reach and product offerings in the mobility, respiratory and long-term care sectors. The company bought DeVilbiss Healthcare in 2015, solidifying its platform in the sleep market. Since then, it has gone on to acquire several other companies, most recently the product line of De Oro Devices in 2025 and Mobility Designed (M+D) in 2024.  

As part of the rebrand, Drive will strategically position its portfolio of trusted brands, including the DeVilbiss Healthcare respiratory line, to recognize their established reputations while leveraging the strength of the Drive Medical name. Those brands include: 

• DeVilbiss by drive 
• Hurrycane by drive 
• M+D by drive 
• Inspired by drive 

Drive says the rebrand will be phased across all communications, products and corporate materials to ensure a seamless transition for customers, partners and employees worldwide. 

• Related: In October, Kingswood Capital Management, a Los Angeles-based private equity firm, announced it had signed a definitive agreement to buy Drive DeVilbiss Healthcare from Clayton, Dubilier and Rice (CD&R).